TITLE

Vaccine Oka Varicella-Zoster Virus Genotypes Are Monomorphic in Single Vesicles and Polymorphic in Respiratory Tract Secretions

AUTHOR(S)
Quinlivan, Mark A.; Gershon, Anne A.; Nichols, Richard A.; La Russa, Philip; Steinberg, Sharon P.; Breuer, Judy
PUB. DATE
April 2006
SOURCE
Journal of Infectious Diseases;4/1/2006, Vol. 193 Issue 7, p927
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
We previously found that, after immunization with vaccine Oka varicella-zoster virus, virus obtained from a single vesicle were monomorphic, and virus obtained from different individuals were heterogeneous. Here we show that virus obtained from the lungs of a patient were a mixture of vaccine Oka variants. We hypothesize that complications after immunization are unlikely to be caused by expansion of a single, biologically more virulent clone of virus that either preexists in the vaccine or develops after random mutation of different clones. We hypothesize that some clones are more trophic than others for skin.
ACCESSION #
20302377

 

Related Articles

  • Nucleotide Sequences that Distinguish Oka Vaccine from Parental Oka and Other Varicella-Zoster... Argaw, Takele; Cohen, Jeffrey I.; Klutch, Michael; Lekstrom, Kristen; Yoshikawa, Tetsushi; Asano, Yoshizo; Krause, Philip R. // Journal of Infectious Diseases;3/1/2000, Vol. 181 Issue 3, p1153 

    Identifies nucleotide sequences that distinguish Oka vaccine from parental Oka and other varicella-zoster virus isolates. Predicted difference in amino acid sequences; Stability of nucleotide changes identified in Oka vaccine viruses after passage in human subjects; Factors attributing to the...

  • Similar herpes zoster incidence across Europe:results from a systematic literature review. Pinchinat, Sybil; Cebrián-Cuenca, Ana M.; Bricout, Hélène; Johnson, Robert W. // BMC Infectious Diseases;2013, Vol. 13 Issue 1, p1 

    Background: Herpes zoster (HZ) is caused by reactivation of the varicella-zoster virus (VZV) and mainly affects individuals aged ⩾50 years. The forthcoming European launch of a vaccine against HZ (Zostavax®) prompts the need for a better understanding of the epidemiology of HZ in Europe....

  • Herpes Zoster Vaccination and Corticosteroid Use.  // Clinical Infectious Diseases;8/15/2015, Vol. 61 Issue 4, piii 

    The article discusses a study related to risk of herpes zoster and disseminated varicella zoster in patients taking immunosuppressant drugs at the time of zoster vaccination by T.C. Cheetham and others. Topics discussed include safety, tolerability, and immunogenicity of zoster vaccine,...

  • Should the UK introduce varicella vaccine? Roderick, Marion; Ramanan, Athimalaipet V.; Finn, Adam // Archives of Disease in Childhood;Dec2007, Vol. 92 Issue 12, p1051 

    The article presents a perspective on the paper by Cameron et al about the importance of introducing varicella vaccine in Great Britain. Cameron el al describe 112 children with severe complications of chickenpox reported over a 13-month period. A temporary strategy of immunising all teenagers...

  • Varicella-Zoster—Virus Genotypes in East London: A Prospective Study in Patients with Herpes Zoster. Sengupta, N.; Taha, V.; Scott, F. T.; Leedham-Green, M. E.; Quinlivan, M.; Breuer, J. // Journal of Infectious Diseases;10/1/2007, Vol. 196 Issue 7, p1014 

    A total of 298 patients with herpes zoster were recruited as part of 2 community-based studies in East London between 1998 and 2003. Single nucleotide–polymorphism analysis of 4 regions (genes 1, 21, 37, and 60) found that most genotypes were European strains C and B, representing 58% and...

  • DEVELOPMENT OF A LIVE VARICELLA VACCINE: CURRENT STATUS AND PROSPECTS. Takahashi, Michiaki // Vaccines: Preventing Disease & Protecting Health;2004, p79 

    Information on the development of a live varicella vaccine from a chapter of the book "Vaccines: Preventing Diseases & Protecting Health" is presented. Information on varicella as a contagious disease in children is presented. The formation by varicella-zoster virus (VZV) of distinct foci is...

  • Humoral and Cellular Immunity to Varicella-Zoster Virus: An Overview. Arvin, Ann M. // Journal of Infectious Diseases;Mar2008 Supplement 2, Vol. 197, pS58 

    The author provides an overview of humoral and cellular immunity to varicella-zoster virus (VZV). He cites the responses under conditions of naturally acquired primary VZV infection. He highlights the likely importance of the responses for the initial control of VZV at mucosal sites of...

  • Varicella-Zoster Virus Infections During Pregnancy: Epidemiology, Clinical Symptoms, Diagnosis, Prevention and Therapy. Sauerbrei, Andreas; Wutzler, Peter // Current Pediatric Reviews;2005, Vol. 1 Issue 3, p205 

    Varicella belongs to serious infections during pregnancy. After introduction of prevention by vaccination in several countries, there is a particular interest to learn more about the consequences of maternal varicella for the infant. Pregnant women who contract varicella are at risk of severe...

  • Chickenpox: A vaccine preventable disease. Nash, Sharon // Australian Nursing Journal;Nov2002, Vol. 10 Issue 5, p31 

    Provides information on the prevention of chickenpox, a contagious disease brought about by the varicella zoster virus. Transmission of airborne infections; Symptoms and prevention of chickenpox; Chickenpox vaccination program in Australia.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics